Diabetes Master Clinician Series

Not all osteoporosis cases are created equal. Every patient with osteoporosis carries a high risk of fracture necessitating lifestyle, nutritional, and pharmaceutical intervention. But identifying who falls into the very high risk category can change outcomes. This session explores practical risk stratification for osteoporosis and how it drives individualized therapy selection. Learn to navigate the nuances between anti-resorptive and anabolic options, first-line therapies, and know when to escalate care. We will cover evidence-based guidelines, monitoring strategies, and clinical pearls to optimize bone health and reduce the risk of treatment failure.

Clinicians across the spectrum of experience and specialties can fall into common traps when evaluating and managing thyroid disorders. In just 30 minutes, this high-yield session will uncover three frequent mistakes that can lead to misdiagnosis, unnecessary testing, or overlooked clinical nuances. Participants will leave with actionable tools to refine their approach to thyroid diagnostics, diagnosis, and management. Whether you’re in primary care or a specialty setting, this session will help sharpen your clinical accuracy and confidence in evaluating and managing thyroid disease. Don’t miss this!

Continuous Glucose Monitoring (CGM) is changing and improving the way people living with diabetes can manage their disease.   Ambulatory Glucose Profile (AGP) reports are a tool for providers to utilize during office visits.  They allow for a patient-centered approach and shared-decision making to establish a management plan.  During this fast-paced 30 minutes, you’ll learn five clinical pearls to help improve outcomes for time and range and A1C. Be sure to “treat” yourself to this!

Join us for expert tips in managing the second most common endocrinopathy in primary care—hypothyroidism. Managing this disease can be challenging due to confusing labs, ubiquitous symptoms, and conflicting medical treatment guidelines. These may lead to delays in diagnosis and implementation of appropriate treatment, thus negatively impacting patient health, cognition, and quality of life. In just 30 minutes, equip yourself with insights to enhance your clinical practice and improve patient outcomes.

Diabetes drugs are taking Hollywood by storm.  This includes novel agents like the GLP-1 receptor agonists dulaglutide (Trulicity), semaglutide (Ozempic), and others. There is also the new dual GLP-1/GIP agonist tirzepatide (Mounjaro).  But are these drugs safe?  Are there risks to using in people without diabetes? And is this contributing to shortages for people with diabetes?  This is a “can’t miss” MCS as we learn answers to these questions and all of the practical pearls about these drugs including their safety, dosing, and expected weight loss.  

“Don’t eat anything white” is not enough. As the provider and clinician, you have to say something more, especially if you have just given your patient their diagnosis of pre-diabetes or maybe type 2 diabetes. Understanding your limited visit time with patients, you have to be concise and help people move to action without feeling like they can’t ever eat a potato or piece of bread again. Join us for tips for a quick assessment, helping patients identify their own strategies for change, finding resources and agreeing to go to that important appointment for Medical Nutrition Counseling (MNT) and/or comprehensive education. You don’t have to be the expert, but you have to help people get started. You Can Do This!

Seems ever daunting to keep up with all the changes of type 2 diabetes management? Join us to review the most up-to-date ADA’s standards of care. Topics will include the pharmacotherapy and clinical use of continuous glucose monitoring. Come and take away practical key updates in diabetes in just 30 minutes!